Gomez Jose L, Diaz Maria P, Nino Gustavo, Britto Clemente J
Division of Pulmonary, Critical Care & Sleep Medicine, Department of Internal Medicine, Yale University School of Medicine, New Haven, CT, USA.
Division of Pulmonary and Sleep Medicine, Children's National Medical Center, Washington, DC, USA.
BMC Med Genomics. 2018 Feb 27;11(1):21. doi: 10.1186/s12920-018-0340-3.
Asthma exacerbations are an important cause of morbidity in asthma. Respiratory infections are often involved in asthma exacerbations in both children and adults. Some individuals with asthma have increased susceptibility to viral infections and as a result increased rates of asthma exacerbations. We sought to identify a transcriptomic signature in the blood associated with asthma exacerbations triggered by respiratory infections (AETRI) and determine its association with increased risk for asthma exacerbations.
We conducted a two-step study using publicly available, previously generated transcriptomic signatures in peripheral blood mononuclear cells (PBMCs) from asthmatics to identify novel markers of increased risk for asthma exacerbations. In the 1st step, we identified an in vitro PBMC signature in response to rhinovirus. In the 2nd step, we used the in vitro signature to filter PBMC transcripts in response to asthma exacerbations in an independent in vivo cohort. Three different subgroups were identified and studied in the in vivo cohort: 1. Single AETRI; 2. Multiple AETRIs; and 3. Single non-infectious asthma exacerbations. We performed pathway and network analyses in all independent comparisons. We also performed an immunologic gene set enrichment analysis (GSEA) of the comparison between single AETRI and non-infectious asthma exacerbations.
The in vitro signature identified 4354 differentially expressed genes (DEGs) with a fold change (FC) ≥ 1.2, false discovery rate (FDR) < 0.05. Subsequent analyses filtered by this in vitro signature on an independent cohort of adult asthma identified 238 DEGs (FC≥1.1, FDR < 0.1) in subjects with a single AETRI and no DEGs in single non-infectious asthma exacerbations. A comparison between the response in subjects with single and multiple AETRIs identified two discordant gene subsets. In the largest discordant subset (n = 63 genes) we identified an impaired type I interferon and STAT1 response in multiple AETRIs during the acute phase of the exacerbation and an upregulated STAT1 response at baseline. The STAT1 upregulation at baseline in subjects with multiple AETRIs was accompanied by upregulation of pro-inflammatory molecules including IL-15, interferon-stimulated genes (ISGs), several toll-like receptors 2, - 4, - 5 and - 8 and a triggering receptor expressed on myeloid cells 1 (TREM1) network.
Subjects with asthma and multiple AETRIs display a pro-inflammatory signature at baseline, associated with elevated STAT, IL-15 and ISGs, and an impaired STAT1 response during acute asthma exacerbations.
哮喘急性发作是哮喘发病的重要原因。呼吸道感染常参与儿童和成人的哮喘急性发作。一些哮喘患者对病毒感染的易感性增加,因此哮喘急性发作的发生率也增加。我们试图确定与呼吸道感染引发的哮喘急性发作(AETRI)相关的血液转录组特征,并确定其与哮喘急性发作风险增加的关联。
我们进行了一项两步研究,使用公开可用的、先前在哮喘患者外周血单个核细胞(PBMC)中生成的转录组特征来识别哮喘急性发作风险增加的新标志物。在第一步中,我们确定了对鼻病毒反应的体外PBMC特征。在第二步中,我们使用体外特征来筛选独立体内队列中对哮喘急性发作反应的PBMC转录本。在体内队列中识别并研究了三个不同的亚组:1. 单次AETRI;2. 多次AETRI;3. 单次非感染性哮喘急性发作。我们在所有独立比较中进行了通路和网络分析。我们还对单次AETRI与非感染性哮喘急性发作之间的比较进行了免疫基因集富集分析(GSEA)。
体外特征识别出4354个差异表达基因(DEG),变化倍数(FC)≥1.2,错误发现率(FDR)<0.05。随后在一个独立的成年哮喘队列中用该体外特征进行分析,在单次AETRI的受试者中筛选出238个DEG(FC≥1.1,FDR<0.1),而在单次非感染性哮喘急性发作中未发现DEG。对单次和多次AETRI受试者的反应进行比较,确定了两个不一致的基因子集。在最大的不一致子集中(n = 63个基因),我们发现在急性发作期多次AETRI的受试者中I型干扰素和STAT1反应受损,而在基线时STAT1反应上调。多次AETRI受试者基线时的STAT1上调伴随着促炎分子的上调,包括IL-15、干扰素刺激基因(ISG)、几种Toll样受体2、-4、-5和-8以及髓样细胞表达的触发受体1(TREM1)网络。
患有哮喘和多次AETRI的受试者在基线时表现出促炎特征,与STAT、IL-15和ISG升高以及急性哮喘发作期间STAT1反应受损有关。